Why the study?
Does phosphorylcholine coating of the cardiopulmonary bypass circuit reduce platelet activation and blood loss in adult patients undergoing elective CABG?
Does phosphorylcholine coating of the cardiopulmonary bypass circuit reduce platelet activation and blood loss in adult patients undergoing elective CABG?
Phosphorylcholine coating of cardiopulmonary bypass circuits significantly reduces platelet activation and clinical blood loss during elective CABG.
No takes yet. Share an insight, caveat, or question.
Supports coated CPB circuits in elective CABG to cut bleeding; extends RCT evidence for phosphorylcholine biocompatibility.
Somer et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: